XD

Xinghua Dingli

Description

Xinghua Dingli is an investment company.

Investor Profile

Xinghua Dingli has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xinghua Dingli frequently co-invest with?

Co-Investments: 1
Conswall Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
HK
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Dongfang Jiafu
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Haibang Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Yinxinggu Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
HT Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Haitong Capital
Europe, Lisboa, Portugal, Lisbon
Co-Investments: 1

What are some of recent deals done by Xinghua Dingli?

Gaowei Medicine

Hangzhou, Zhejiang, China

Gaowei Medicine provides new drug solutions for major intractable diseases such as cancer and neurodegenerative diseases.

BiotechnologyHealth CarePharmaceutical
SeedNov 10, 2025
Healsun Biopharm

Hangzhou, Zhejiang, China

Healsun Biopharm is a Biopharmaceutical company that focuses on antibody/recombinant protein CRO/CDMO

BiopharmaBiotechnologyHealth CarePharmaceutical
Series BAug 19, 2022
Amount Raised: $36,672,485